BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1328987)

  • 1. Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product.
    Freund R; Bronson RT; Benjamin TL
    Oncogene; 1992 Oct; 7(10):1979-87. PubMed ID: 1328987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations within the hamster polyomavirus large T antigen domain involved in pRb binding impair virus productive cycle and immortalization capacity.
    Goutebroze L; de la Roche Saint Andre C; Scherneck S; Feunteun J
    Oncogene; 1993 Mar; 8(3):685-93. PubMed ID: 8382359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lytic functions of mutant polyomavirus large T-antigen with deletion of retinoblastoma protein-binding motif.
    Söderbärg K; Magnusson G
    Virology; 1993 Mar; 193(1):281-8. PubMed ID: 8382398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
    Conzen SD; Cole CN
    Oncogene; 1995 Dec; 11(11):2295-302. PubMed ID: 8570180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J; Freund R
    Oncogene; 1997 Apr; 14(16):1923-31. PubMed ID: 9150359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
    Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
    Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
    Hara E; Uzman JA; Dimri GP; Nehlin JO; Testori A; Campisi J
    Dev Genet; 1996; 18(2):161-72. PubMed ID: 8934878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.
    Larose A; Dyson N; Sullivan M; Harlow E; Bastin M
    J Virol; 1991 May; 65(5):2308-13. PubMed ID: 2016761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus.
    Chen J; Tobin GJ; Pipas JM; Van Dyke T
    Oncogene; 1992 Jun; 7(6):1167-75. PubMed ID: 1317542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway.
    McCabe MT; Low JA; Imperiale MJ; Day ML
    Oncogene; 2006 May; 25(19):2727-35. PubMed ID: 16547506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyomavirus tumorantigens have a profound effect on gene expression in mouse fibroblasts.
    Klucky B; Koch B; Radolf M; Steinlein P; Wintersberger E
    Oncogene; 2004 Jun; 23(27):4707-21. PubMed ID: 15122341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on polyomavirus T-antigen function of mutations in a conserved leucine-rich segment of the DnaJ domain.
    Li H; Söderbärg K; Houshmand H; You ZY; Magnusson G
    J Virol; 2001 Mar; 75(5):2253-61. PubMed ID: 11160729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular proteins that are targetted by DNA tumor viruses for transformation.
    Dyson N; Buchkovich K; Whyte P; Harlow E
    Princess Takamatsu Symp; 1989; 20():191-8. PubMed ID: 2488232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
    Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
    Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
    Lukacher AE; Wilson CS
    J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limits of transforming competence of SV40 nuclear and cytoplasmic large T mutants with altered Rb binding sequences.
    Tedesco D; Fischer-Fantuzzi L; Vesco C
    Oncogene; 1993 Mar; 8(3):549-57. PubMed ID: 8382355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SV40 large T antigen induced apoptosis by small T antigen.
    Kolzau T; Hansen RS; Zahra D; Reddel RR; Braithwaite AW
    Oncogene; 1999 Sep; 18(40):5598-603. PubMed ID: 10523837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.